Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products

Vista sencilla de ítem
cepal.bibLevelDocumento Completo
cepal.callNumberLC/L.4248
cepal.docTypeSeries
cepal.jobNumberS1601006_en
cepal.regionalOfficeWashington
cepal.sdg9
cepal.sdg17
cepal.topicEngINTERNATIONAL TRADE
cepal.topicEngTRADE POLICY AND TRADE AGREEMENTS
cepal.topicSpaCOMERCIO INTERNACIONAL
cepal.topicSpaPOLÍTICA COMERCIAL Y ACUERDOS COMERCIALES
cepal.workareaEngINTERNATIONAL TRADE AND INTEGRATION
cepal.workareaSpaCOMERCIO INTERNACIONAL E INTEGRACIÓN
dc.contributor.authorArtecona, Raquel
dc.contributor.authorPlank-Brumback, Rosine M.
dc.coverage.spatialEngUNITED STATES
dc.coverage.spatialSpaESTADOS UNIDOS
dc.date.accessioned2016-11-11T15:30:56Z
dc.date.available2016-11-11T15:30:56Z
dc.date.issued2016-11
dc.description.abstractThis study addresses the balance struck under the Trans-Pacific Partnership Agreement (TPPA) between the right to health and access to medicines and the need to maintain the economic incentives to spur innovation and research and development through intellectual property protection. The analysis focuses on the patent and data-related intellectual property protection provisions of the TPPA, specifically regarding pharmaceutical (small-molecule and biologic) products, including on patent duration, linkage and term extensions as well as clinical test data protection and market exclusivity. Special attention is paid to the United States and its negotiating position with respect to those aspects of intellectual property rights, as it has been and remains the world’s principal demandeur for high intellectual property rights (IPR) standards in trade agreements, including the TPPA.
dc.description.tableOfContentsAbstract .-- Introduction .-- I. Key trends in the global, regional and U.S. pharmaceutical industries .-- II. Patent and regulatory data-related protection on pharmaceutical products in TPP .-- III. Congressional mandates on intellectual property protection on pharmaceutical products .-- IV. Conclusions.
dc.formatTexto
dc.format.extent55 páginas.
dc.format.mimetypeapplication/pdf
dc.identifier.unSymbolLC/L.4248
dc.identifier.unSymbolLC/WAS/L.143
dc.identifier.urihttps://hdl.handle.net/11362/40729
dc.language.isoeng
dc.physicalDescription55 p.
dc.publisherECLAC
dc.publisher.placeWashington, D.C.
dc.relation.isPartOfSeriesStudies and Perspectives Series (Washington, DC)
dc.relation.isPartOfSeriesNo16
dc.rights.coarDisponible
dc.subject.unbisEngECONOMIC AGREEMENTS
dc.subject.unbisEngINTERNATIONAL TRADE
dc.subject.unbisEngTRADE NEGOTIATIONS
dc.subject.unbisEngPHARMACEUTICALS
dc.subject.unbisEngINNOVATIONS
dc.subject.unbisEngPATENTS
dc.subject.unbisEngINTELLECTUAL PROPERTY
dc.subject.unbisSpaACUERDOS ECONOMICOS
dc.subject.unbisSpaCOMERCIO INTERNACIONAL
dc.subject.unbisSpaNEGOCIACIONES COMERCIALES
dc.subject.unbisSpaPRODUCTOS FARMACEUTICOS
dc.subject.unbisSpaINNOVACIONES
dc.subject.unbisSpaPATENTES
dc.subject.unbisSpaPROPIEDAD INTELECTUAL
dc.titleAccess to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products
dc.type.coarlibro
dspace.entity.typePublication
relation.isAuthorOfPublicationd825f5bc-67af-4b54-9a46-e49893de454f
relation.isAuthorOfPublication732cda85-d6cd-4d75-840c-78408791d812
relation.isAuthorOfPublication.latestForDiscoveryd825f5bc-67af-4b54-9a46-e49893de454f
Descargar
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
S1601006_en.pdf
Tamaño:
620.24 KB
Formato:
Adobe Portable Document Format
Descripción:
Document in English
Descargar
Colecciones
Studies and Perspectives – ECLAC Office in Washington